Companies developing vaccines based on the envelope proteins of HIV are not overly concerned with findings from the lab of Jay Levy at the University of California, San Francisco, that some antibodies to the envelope may enhance the infectiveness of viral strains that co-exist in the body.
The research, published in the Proceedings of